US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Agenus

7.85

+0.63008.73%

Post-market: 7.81-0.0444-0.57%19:35 EDT

Volume:2.08M

Turnover:16.06M

Market Cap:353.41M

PE:3.14

High:7.88

Open:7.48

Low:7.33

Close:7.22

52wk High:8.85

52wk Low:2.71

Shares:45.02M

Float Shares:40.38M

Volume Ratio:2.76

T/O Rate:5.16%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.50

EPS(LYR):-0.0034

ROE:-1278.83%

ROA:12.53%

PB:-1.78

PE(LYR):-2,311.54

Loading ...

Overview Company News Filings

Agenus shareholders approve 5 million-share increase to 2019 equity plan at annual meeting

Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion

Agenus announces virtual annual shareholders meeting

Backlash over Trump's $1.776 billion fund tests Blanche's bid for US attorney general

Agenus reports Phase 2 BOT+BAL melanoma trial shows 22% response rate

Agenus says AI model predicts BOT+BAL response, survival in MSS metastatic colorectal cancer

Agenus Announces Resignation of Principal Accounting Officer

Agenus announces publication of Phase 1b BOT+BAL data

Agenus principal accounting officer Charette resigns effective May 29

Agenus reports Phase 1b BOT+BAL trial shows 17% response in post-immunotherapy HCC

MiNK Therapeutics Q1 FY26 net loss narrows to $2.74 million

Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained

Agenus Inc reports results for the quarter ended March 31 - Earnings Summary

Agenus reports Q1 revenue $33.7M vs. $24.1M last year

Agenus provides 2026 strategic priorities

Agenus announces conclusion of SEC investigation with no enforcement action

Agenus Q1 Sales $33.700M May Not Be Comparable To $129.500M Estimate, Net Income Of $39.2M Vs. Loss of $26.4M YoY

Benzinga Earnings

Immuno-oncology developer Agenus' Q1 revenue rises, posts profit

Press Release: Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development

Agenus Q1 FY26 net income swings to $39.2 million; revenue rises to $33.7 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/AGEN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"AGEN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","market":"US","secType":"STK","nameCN":"Agenus","latestPrice":7.85,"timestamp":1789761600000,"preClose":7.22,"halted":0,"volume":2084681,"hourTrading":{"tag":"盘后","latestPrice":7.8056,"preClose":7.85,"latestTime":"19:35 EDT","volume":366288,"amount":2874979.7943,"timestamp":1789774542875,"change":-0.0444,"changeRate":-0.005656,"amplitude":0.017834},"delay":0,"changeRate":0.08725761772853184,"floatShares":40378600,"shares":45020400,"eps":2.500181,"marketStatus":"Closed","change":0.63,"latestTime":"09-18 16:00:00 EDT","open":7.48,"high":7.88,"low":7.33,"amount":16056934.361626001,"amplitude":0.076177,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.500181,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789977600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":949640400000,"exchange":"NASDAQ","adjPreClose":7.22,"preHourTrading":{"tag":"盘前","latestPrice":7.54,"preClose":7.22,"latestTime":"09:28 EDT","volume":31854,"amount":235411.316988,"timestamp":1789738110058,"change":0.32,"changeRate":0.044321,"amplitude":0.072022},"postHourTrading":{"tag":"盘后","latestPrice":7.8056,"preClose":7.85,"latestTime":"19:35 EDT","volume":366288,"amount":2874979.7943,"timestamp":1789774542875,"change":-0.0444,"changeRate":-0.005656,"amplitude":0.017834},"volumeRatio":2.761323,"impliedVol":0.8601,"impliedVolPercentile":0.2988},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGEN\",,,,,undefined,":{"symbol":"AGEN","floatShares":40378600,"roa":"12.53%","roe":"-1278.83%","lyrEps":-0.003396,"volumeRatio":2.761323,"shares":45020400,"dividePrice":0,"high":7.88,"amplitude":0.076177,"preClose":7.22,"low":7.33,"week52Low":2.71,"pbRate":"-1.78","psRate":"2.66","week52High":8.85,"institutionHeld":0.0374,"latestPrice":7.85,"eps":2.500181,"divideRate":0,"volume":2084681,"delay":0,"ttmEps":2.500181,"open":7.48,"prevYearClose":3.14,"prevWeekClose":6.94,"prevMonthClose":7.61,"prevQuarterClose":3.06,"fiveDayClose":6.94,"twentyDayClose":7.49,"sixtyDayClose":2.92,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGEN\",params:#limit:5,,,undefined,":[{"date":"2026-08-06","symbol":"AGEN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":0.05,"defaultRemindTime":1786003200000,"name":null,"time":"Pre-MKt","dateTimestamp":1785988800000,"actualEps":null},{"market":"US","date":"2026-05-11","symbol":"AGEN","fiscalQuarterEnding":"2026/03","expectedEps":2.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"pre","actualEps":1.02},{"market":"US","date":"2026-03-16","symbol":"AGEN","fiscalQuarterEnding":"2025/12","expectedEps":-1.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1773633600000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2025-11-10","symbol":"AGEN","fiscalQuarterEnding":"2025/09","expectedEps":2.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":1.94},{"market":"US","date":"2025-08-11","symbol":"AGEN","fiscalQuarterEnding":"2025/06","expectedEps":-0.78,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGEN\",market:\"US\",,,undefined,":[{"executeDate":"2023-04-26","recordDate":"2023-04-17","paymentDate":"2023-05-01","value":0.0146,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGEN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1749096000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGEN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGEN","date":"2026-09-17","current":3.139773,"percent":0.827815,"low":-44.01113,"twenty":-3.338362,"median":-0.895633,"eighty":2.130035,"high":1612.730861,"avg":52.906539,"sd":234.742329,"marketCap":324597134},"quantilePoints":[{"date":"2021-09-24","current":-6.093097,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1375376405},{"date":"2021-10-01","current":-5.494114,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1240169911},{"date":"2021-10-08","current":-5.907205,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1333415769},{"date":"2021-10-15","current":-5.483787,"twenty":-4.516653,"median":-3.714145,"eighty":-2.836115,"marketCap":1237838764},{"date":"2021-10-22","current":-4.14124,"twenty":-4.510274,"median":-3.714145,"eighty":-2.836115,"marketCap":934789726},{"date":"2021-10-29","current":-3.965676,"twenty":-4.491197,"median":-3.714145,"eighty":-2.836115,"marketCap":895160236},{"date":"2021-11-05","current":-4.296149,"twenty":-4.50337,"median":-3.720603,"eighty":-2.836115,"marketCap":969756923},{"date":"2021-11-12","current":250.504017,"twenty":-4.492661,"median":-3.714145,"eighty":-2.767971,"marketCap":996504978},{"date":"2021-11-19","current":225.324489,"twenty":-4.480962,"median":-3.706852,"eighty":-2.716856,"marketCap":896340818},{"date":"2021-11-26","current":208.538138,"twenty":-4.480962,"median":-3.702346,"eighty":-2.673681,"marketCap":829564711},{"date":"2021-12-03","current":188.523641,"twenty":-4.480962,"median":-3.699858,"eighty":-2.645398,"marketCap":749947045},{"date":"2021-12-10","current":207.892509,"twenty":-4.480962,"median":-3.687712,"eighty":-2.594402,"marketCap":826996399},{"date":"2021-12-17","current":229.843891,"twenty":-4.480962,"median":-3.681489,"eighty":-2.55596,"marketCap":914319000},{"date":"2021-12-23","current":231.135149,"twenty":-4.480962,"median":-3.675884,"eighty":-2.518274,"marketCap":919455624},{"date":"2021-12-31","current":207.892509,"twenty":-4.480962,"median":-3.670231,"eighty":-2.488017,"marketCap":826996399},{"date":"2022-01-07","current":193.043044,"twenty":-4.478774,"median":-3.656664,"eighty":-2.484485,"marketCap":767925228},{"date":"2022-01-14","current":196.916817,"twenty":-4.478774,"median":-3.656664,"eighty":-2.460584,"marketCap":783335099},{"date":"2022-01-21","current":173.028548,"twenty":-4.478774,"median":-3.656664,"eighty":-2.442206,"marketCap":688307562},{"date":"2022-01-28","current":169.800403,"twenty":-4.476586,"median":-3.655673,"eighty":-2.416994,"marketCap":675466003},{"date":"2022-02-04","current":154.305309,"twenty":-4.476586,"median":-3.654546,"eighty":-2.368992,"marketCap":613826520},{"date":"2022-02-11","current":157.533454,"twenty":-4.476586,"median":-3.646266,"eighty":-2.309108,"marketCap":626668079},{"date":"2022-02-18","current":164.635372,"twenty":-4.473257,"median":-3.633585,"eighty":-2.287512,"marketCap":654919509},{"date":"2022-02-25","current":172.382919,"twenty":-4.472972,"median":-3.627385,"eighty":-2.273796,"marketCap":685739250},{"date":"2022-03-04","current":-31.276341,"twenty":-4.487372,"median":-3.624232,"eighty":-2.265661,"marketCap":748317732},{"date":"2022-03-11","current":-30.201553,"twenty":-4.515269,"median":-3.624232,"eighty":-2.265661,"marketCap":722602346},{"date":"2022-03-18","current":-31.813735,"twenty":-4.534668,"median":-3.624232,"eighty":-2.265661,"marketCap":761175425},{"date":"2022-03-25","current":-29.019285,"twenty":-4.545222,"median":-3.624232,"eighty":-2.265661,"marketCap":694315422},{"date":"2022-04-01","current":-27.622061,"twenty":-4.554265,"median":-3.624232,"eighty":-2.265661,"marketCap":660885420},{"date":"2022-04-08","current":-25.687441,"twenty":-4.583796,"median":-3.632439,"eighty":-2.265661,"marketCap":614597725},{"date":"2022-04-14","current":-25.150047,"twenty":-4.591972,"median":-3.639532,"eighty":-2.265661,"marketCap":601740032},{"date":"2022-04-22","current":-22.355598,"twenty":-4.602401,"median":-3.656664,"eighty":-2.265661,"marketCap":534880028},{"date":"2022-04-29","current":-20.898026,"twenty":-4.613626,"median":-3.662921,"eighty":-2.265661,"marketCap":500006178},{"date":"2022-05-06","current":-18.864705,"twenty":-4.627212,"median":-3.670231,"eighty":-2.265661,"marketCap":451356928},{"date":"2022-05-13","current":-23.781378,"twenty":-4.638718,"median":-3.674393,"eighty":-2.265661,"marketCap":441715308},{"date":"2022-05-20","current":-22.90599,"twenty":-4.670065,"median":-3.690098,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-05-27","current":-23.489582,"twenty":-4.693902,"median":-3.704311,"eighty":-2.265661,"marketCap":436295489},{"date":"2022-06-03","current":-24.510868,"twenty":-4.720153,"median":-3.714507,"eighty":-2.265661,"marketCap":455264858},{"date":"2022-06-10","current":-21.301111,"twenty":-4.748522,"median":-3.733485,"eighty":-2.265661,"marketCap":395646841},{"date":"2022-06-17","current":-22.90599,"twenty":-4.769115,"median":-3.74907,"eighty":-2.265661,"marketCap":425455849},{"date":"2022-06-24","current":-28.934653,"twenty":-4.783709,"median":-3.750097,"eighty":-2.26134,"marketCap":537432248},{"date":"2022-07-01","current":-29.848379,"twenty":-4.814658,"median":-3.750097,"eighty":-2.26134,"marketCap":554403792},{"date":"2022-07-08","current":-41.269953,"twenty":-4.847014,"median":-3.750097,"eighty":-2.26134,"marketCap":766548101},{"date":"2022-07-15","current":-43.858843,"twenty":-4.889306,"median":-3.750097,"eighty":-2.26134,"marketCap":814634144},{"date":"2022-07-22","current":-40.508514,"twenty":-4.895841,"median":-3.750097,"eighty":-2.26134,"marketCap":752405147},{"date":"2022-07-29","current":-39.290213,"twenty":-4.909329,"median":-3.750097,"eighty":-2.26134,"marketCap":729776421},{"date":"2022-08-05","current":-40.356227,"twenty":-4.945769,"median":-3.750097,"eighty":-2.26134,"marketCap":749576556},{"date":"2022-08-12","current":45.998677,"twenty":-4.954877,"median":-3.740203,"eighty":-2.241781,"marketCap":840993818},{"date":"2022-08-19","current":43.210879,"twenty":-4.954877,"median":-3.718267,"eighty":-2.228928,"marketCap":790024496},{"date":"2022-08-26","current":41.352346,"twenty":-4.954877,"median":-3.706852,"eighty":-2.208814,"marketCap":756044948},{"date":"2022-09-02","current":39.803569,"twenty":-4.954877,"median":-3.693851,"eighty":-2.187438,"marketCap":727728658},{"date":"2022-09-09","current":41.662102,"twenty":-4.954877,"median":-3.677376,"eighty":-2.178074,"marketCap":761708206},{"date":"2022-09-16","current":36.241382,"twenty":-4.954877,"median":-3.663474,"eighty":-2.143769,"marketCap":662601190},{"date":"2022-09-23","current":32.98895,"twenty":-4.954877,"median":-3.652457,"eighty":-2.114419,"marketCap":603136981},{"date":"2022-09-30","current":31.749929,"twenty":-4.935664,"median":-3.633097,"eighty":-2.043977,"marketCap":580483949},{"date":"2022-10-07","current":41.507224,"twenty":-4.900526,"median":-3.619552,"eighty":-2.004987,"marketCap":758876577},{"date":"2022-10-14","current":37.790159,"twenty":-4.854232,"median":-3.602328,"eighty":-1.947842,"marketCap":690917480},{"date":"2022-10-21","current":40.887713,"twenty":-4.818365,"median":-3.587597,"eighty":-1.883135,"marketCap":747550061},{"date":"2022-10-28","current":39.493814,"twenty":-4.818365,"median":-3.577659,"eighty":-1.827749,"marketCap":722065400},{"date":"2022-11-04","current":37.790159,"twenty":-4.818365,"median":-3.57269,"eighty":-1.797631,"marketCap":690917480},{"date":"2022-11-11","current":-3.566927,"twenty":-4.818365,"median":-3.572342,"eighty":-1.787835,"marketCap":765077329},{"date":"2022-11-18","current":-4.348525,"twenty":-4.818365,"median":-3.575678,"eighty":-1.787835,"marketCap":932723756},{"date":"2022-11-25","current":-3.993253,"twenty":-4.818365,"median":-3.586647,"eighty":-1.787835,"marketCap":856520834},{"date":"2022-12-02","current":-4.220627,"twenty":-4.818365,"median":-3.595749,"eighty":-1.787835,"marketCap":905290704},{"date":"2022-12-09","current":-3.439029,"twenty":-4.818365,"median":-3.602328,"eighty":-1.787835,"marketCap":737644277},{"date":"2022-12-16","current":-3.396397,"twenty":-4.818365,"median":-3.609154,"eighty":-1.787835,"marketCap":728499927},{"date":"2022-12-23","current":-3.481662,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":746788628},{"date":"2022-12-30","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-06","current":-3.410608,"twenty":-4.818365,"median":-3.609226,"eighty":-1.787835,"marketCap":731548044},{"date":"2023-01-13","current":-4.192205,"twenty":-4.818365,"median":-3.630887,"eighty":-1.787835,"marketCap":899194470},{"date":"2023-01-20","current":-3.836934,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":822991549},{"date":"2023-01-27","current":-3.737457,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":801654731},{"date":"2023-02-03","current":-3.652192,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":783366030},{"date":"2023-02-10","current":-3.154812,"twenty":-4.818365,"median":-3.640074,"eighty":-1.787835,"marketCap":676681940},{"date":"2023-02-17","current":-3.112179,"twenty":-4.818365,"median":-3.637981,"eighty":-1.787835,"marketCap":667537590},{"date":"2023-02-24","current":-2.813751,"twenty":-4.818365,"median":-3.636886,"eighty":-1.787835,"marketCap":603527136},{"date":"2023-03-03","current":-2.78533,"twenty":-4.787082,"median":-3.623771,"eighty":-1.787835,"marketCap":597430902},{"date":"2023-03-10","current":-2.13163,"twenty":-4.761022,"median":-3.609154,"eighty":-1.787835,"marketCap":457217527},{"date":"2023-03-17","current":-2.568557,"twenty":-4.722497,"median":-3.595749,"eighty":-1.787835,"marketCap":565272567},{"date":"2023-03-24","current":-2.251264,"twenty":-4.720153,"median":-3.586647,"eighty":-1.787835,"marketCap":495444779},{"date":"2023-03-31","current":-2.296592,"twenty":-4.720153,"median":-3.576669,"eighty":-1.787835,"marketCap":505420178},{"date":"2023-04-06","current":-2.190828,"twenty":-4.720153,"median":-3.573126,"eighty":-1.787835,"marketCap":482144248},{"date":"2023-04-14","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-04-21","current":-2.538338,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":558622302},{"date":"2023-04-28","current":-2.266374,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":498769912},{"date":"2023-05-05","current":-2.375309,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":522743683},{"date":"2023-05-12","current":-1.990022,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":478327553},{"date":"2023-05-18","current":-2.136839,"twenty":-4.720153,"median":-3.566927,"eighty":-1.787835,"marketCap":512847659},{"date":"2023-05-26","current":-2.049621,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":491915102},{"date":"2023-06-02","current":-2.311274,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":554712774},{"date":"2023-06-08","current":-2.732828,"twenty":-4.720153,"median":-3.567324,"eighty":-1.787835,"marketCap":655886802},{"date":"2023-06-16","current":-2.631073,"twenty":-4.720153,"median":-3.570015,"eighty":-1.787835,"marketCap":631465485},{"date":"2023-06-23","current":-2.587464,"twenty":-4.720153,"median":-3.572309,"eighty":-1.812326,"marketCap":620999207},{"date":"2023-06-30","current":-2.427565,"twenty":-4.720153,"median":-3.572309,"eighty":-1.898861,"marketCap":582622851},{"date":"2023-07-07","current":-2.282202,"twenty":-4.720153,"median":-3.572325,"eighty":-1.952741,"marketCap":547735255},{"date":"2023-07-14","current":-2.689219,"twenty":-4.720153,"median":-3.572342,"eighty":-1.990022,"marketCap":645420524},{"date":"2023-07-21","current":-2.383956,"twenty":-4.721325,"median":-3.572516,"eighty":-2.032983,"marketCap":572156572},{"date":"2023-07-28","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.049401,"marketCap":505870140},{"date":"2023-08-04","current":-2.107766,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":505870140},{"date":"2023-08-11","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-18","current":-1.908081,"twenty":-4.722497,"median":-3.57269,"eighty":-2.107766,"marketCap":501035286},{"date":"2023-08-25","current":-1.922536,"twenty":-4.722497,"median":-3.57269,"eighty":-2.122302,"marketCap":504831008},{"date":"2023-09-01","current":-1.994812,"twenty":-4.72367,"median":-3.573126,"eighty":-2.122302,"marketCap":523809618},{"date":"2023-09-06","current":-1.85026,"twenty":-4.724842,"median":-3.573563,"eighty":-2.122823,"marketCap":485852399},{"date":"2023-09-15","current":-1.87917,"twenty":-4.730669,"median":-3.575678,"eighty":-2.125954,"marketCap":493443843},{"date":"2023-09-21","current":-1.734619,"twenty":-4.735324,"median":-3.575678,"eighty":-2.126721,"marketCap":455486624},{"date":"2023-09-27","current":-1.662343,"twenty":-4.744635,"median":-3.575678,"eighty":-2.131737,"marketCap":436508015},{"date":"2023-10-05","current":-1.459971,"twenty":-4.751199,"median":-3.576669,"eighty":-2.134128,"marketCap":383367908},{"date":"2023-10-13","current":-1.474426,"twenty":-4.755016,"median":-3.579398,"eighty":-2.135507,"marketCap":387163630},{"date":"2023-10-20","current":-1.392032,"twenty":-4.756925,"median":-3.581138,"eighty":-2.137245,"marketCap":365528016},{"date":"2023-10-27","current":-1.170868,"twenty":-4.758834,"median":-3.584493,"eighty":-2.147035,"marketCap":307453471},{"date":"2023-11-03","current":-1.228688,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":322636358},{"date":"2023-11-10","current":-1.049912,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":285969685},{"date":"2023-11-17","current":-0.987001,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":267046829},{"date":"2023-11-24","current":-0.97276,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":263193725},{"date":"2023-12-01","current":-1.095712,"twenty":-4.758834,"median":-3.584493,"eighty":-2.152459,"marketCap":296460130},{"date":"2023-12-08","current":-1.142806,"twenty":-4.758834,"median":-3.584493,"eighty":-2.143769,"marketCap":309202079},{"date":"2023-12-15","current":-1.073293,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":290394352},{"date":"2023-12-22","current":-1.096417,"twenty":-4.758834,"median":-3.584493,"eighty":-2.134619,"marketCap":296650878},{"date":"2023-12-29","current":-1.142101,"twenty":-4.758834,"median":-3.584493,"eighty":-2.135507,"marketCap":309011331},{"date":"2024-01-05","current":-1.095148,"twenty":-4.758834,"median":-3.58557,"eighty":-2.134619,"marketCap":296307532},{"date":"2024-01-12","current":-1.007446,"twenty":-4.758834,"median":-3.58557,"eighty":-2.125169,"marketCap":272578514},{"date":"2024-01-19","current":-0.794394,"twenty":-4.758834,"median":-3.586647,"eighty":-2.107766,"marketCap":214934548},{"date":"2024-01-26","current":-0.845719,"twenty":-4.758834,"median":-3.58557,"eighty":-2.075999,"marketCap":228820983},{"date":"2024-02-02","current":-0.895633,"twenty":-4.758834,"median":-3.58557,"eighty":-2.035084,"marketCap":242325923},{"date":"2024-02-09","current":-0.983194,"twenty":-4.758834,"median":-3.58557,"eighty":-1.99098,"marketCap":266016791},{"date":"2024-02-16","current":-0.964752,"twenty":-4.758834,"median":-3.58557,"eighty":-1.939882,"marketCap":261027212},{"date":"2024-02-23","current":-0.996035,"twenty":-4.758834,"median":-3.58557,"eighty":-1.896517,"marketCap":269491233},{"date":"2024-03-01","current":-0.988965,"twenty":-4.758834,"median":-3.584493,"eighty":-1.85026,"marketCap":267578233},{"date":"2024-03-08","current":-1.035018,"twenty":-4.758834,"median":-3.584493,"eighty":-1.792843,"marketCap":280038593},{"date":"2024-03-15","current":-0.975875,"twenty":-4.758834,"median":-3.584493,"eighty":-1.65367,"marketCap":251226366},{"date":"2024-03-22","current":-0.958317,"twenty":-4.758834,"median":-3.584493,"eighty":-1.538029,"marketCap":235516863},{"date":"2024-03-28","current":-0.94843,"twenty":-4.758834,"median":-3.584493,"eighty":-1.484545,"marketCap":233087127},{"date":"2024-04-05","current":-0.862349,"twenty":-4.758834,"median":-3.58557,"eighty":-1.295732,"marketCap":211931663},{"date":"2024-04-12","current":-0.755983,"twenty":-4.758834,"median":-3.58557,"eighty":-1.171601,"marketCap":185791046},{"date":"2024-04-19","current":-0.423589,"twenty":-4.758834,"median":-3.58557,"eighty":-1.150283,"marketCap":104101634},{"date":"2024-04-26","current":-0.707402,"twenty":-4.758834,"median":-3.584493,"eighty":-1.141509,"marketCap":173851824},{"date":"2024-05-03","current":-1.069542,"twenty":-4.758834,"median":-3.584493,"eighty":-1.12724,"marketCap":262851728},{"date":"2024-05-10","current":-1.028064,"twenty":-4.758834,"median":-3.584493,"eighty":-1.10327,"marketCap":246111338},{"date":"2024-05-17","current":-0.921047,"twenty":-4.758834,"median":-3.575678,"eighty":-1.095374,"marketCap":220492240},{"date":"2024-05-24","current":-1.083327,"twenty":-4.758834,"median":-3.572309,"eighty":-1.076226,"marketCap":259340873},{"date":"2024-05-31","current":-1.325431,"twenty":-4.758834,"median":-3.56471,"eighty":-1.076226,"marketCap":317298833},{"date":"2024-06-07","current":-1.452623,"twenty":-4.758834,"median":-3.552584,"eighty":-1.076226,"marketCap":347747762},{"date":"2024-06-14","current":-1.4035,"twenty":-4.758834,"median":-3.542773,"eighty":-1.074759,"marketCap":335988176},{"date":"2024-06-21","current":-1.190344,"twenty":-4.758834,"median":-3.537907,"eighty":-1.073293,"marketCap":284959971},{"date":"2024-06-28","current":-1.238589,"twenty":-4.762116,"median":-3.528963,"eighty":-1.072785,"marketCap":296509565},{"date":"2024-07-05","current":-1.274554,"twenty":-4.762116,"median":-3.51515,"eighty":-1.072785,"marketCap":305119262},{"date":"2024-07-12","current":-1.349992,"twenty":-4.762116,"median":-3.508598,"eighty":-1.072785,"marketCap":323178626},{"date":"2024-07-15","current":-1.368413,"twenty":-4.762116,"median":-3.503383,"eighty":-1.072785,"marketCap":327588471},{"date":"2024-08-02","current":-0.523681,"twenty":-4.777562,"median":-3.481662,"eighty":-1.070617,"marketCap":125365588},{"date":"2024-08-09","current":-0.509715,"twenty":-4.777562,"median":-3.475136,"eighty":-1.052035,"marketCap":113899848},{"date":"2024-08-16","current":-0.499096,"twenty":-4.777562,"median":-3.475136,"eighty":-1.0353,"marketCap":111526934},{"date":"2024-08-23","current":-0.528057,"twenty":-4.777562,"median":-3.467451,"eighty":-1.011394,"marketCap":117998517},{"date":"2024-08-30","current":-0.481719,"twenty":-4.777562,"median":-3.467451,"eighty":-1.002749,"marketCap":107643985},{"date":"2024-09-06","current":-0.482684,"twenty":-4.777562,"median":-3.465995,"eighty":-0.993799,"marketCap":107859705},{"date":"2024-09-13","current":-0.572464,"twenty":-4.777562,"median":-3.432608,"eighty":-0.988904,"marketCap":127921610},{"date":"2024-09-20","current":-0.578256,"twenty":-4.777562,"median":-3.410608,"eighty":-0.985676,"marketCap":129215926},{"date":"2024-09-27","current":-0.499096,"twenty":-4.777562,"median":-3.383717,"eighty":-0.975109,"marketCap":111526934},{"date":"2024-10-04","current":-0.440208,"twenty":-4.777562,"median":-3.383717,"eighty":-0.972752,"marketCap":98368050},{"date":"2024-10-11","current":-0.410282,"twenty":-4.777562,"median":-3.383717,"eighty":-0.959969,"marketCap":91680749},{"date":"2024-10-18","current":-0.441174,"twenty":-4.777562,"median":-3.383717,"eighty":-0.952469,"marketCap":98583770},{"date":"2024-10-25","current":-0.425728,"twenty":-4.777562,"median":-3.383717,"eighty":-0.940321,"marketCap":95132259},{"date":"2024-10-31","current":-0.423797,"twenty":-4.777562,"median":-3.383717,"eighty":-0.930994,"marketCap":94700820},{"date":"2024-11-08","current":-0.37939,"twenty":-4.777562,"median":-3.374713,"eighty":-0.91572,"marketCap":84777728},{"date":"2024-11-15","current":-0.285452,"twenty":-4.777562,"median":-3.303677,"eighty":-0.897325,"marketCap":64981233},{"date":"2024-11-22","current":-0.294727,"twenty":-4.761022,"median":-3.28271,"eighty":-0.869324,"marketCap":67092536},{"date":"2024-11-29","current":-0.352436,"twenty":-4.761022,"median":-3.252725,"eighty":-0.844647,"marketCap":80229537},{"date":"2024-12-06","current":-0.323581,"twenty":-4.761022,"median":-3.219896,"eighty":-0.822086,"marketCap":73661037},{"date":"2024-12-13","current":-0.317398,"twenty":-4.761022,"median":-3.168467,"eighty":-0.736551,"marketCap":72253501},{"date":"2024-12-20","current":-0.284422,"twenty":-4.761022,"median":-3.145635,"eighty":-0.595633,"marketCap":64746644},{"date":"2024-12-27","current":-0.289574,"twenty":-4.761022,"median":-3.106339,"eighty":-0.570147,"marketCap":65919590},{"date":"2025-01-03","current":-0.318429,"twenty":-4.761022,"median":-3.077193,"eighty":-0.552626,"marketCap":72488090},{"date":"2025-01-10","current":-0.350375,"twenty":-4.762116,"median":-3.05033,"eighty":-0.532191,"marketCap":79760358},{"date":"2025-01-17","current":-0.324612,"twenty":-4.762116,"median":-3.026485,"eighty":-0.512032,"marketCap":73895626},{"date":"2025-01-24","current":-0.387473,"twenty":-4.762116,"median":-2.980497,"eighty":-0.499868,"marketCap":88205573},{"date":"2025-01-31","current":-0.364802,"twenty":-4.762116,"median":-2.925709,"eighty":-0.495234,"marketCap":83044608},{"date":"2025-02-07","current":-0.385412,"twenty":-4.762116,"median":-2.870595,"eighty":-0.491533,"marketCap":87736394},{"date":"2025-02-14","current":-0.36068,"twenty":-4.762116,"median":-2.79954,"eighty":-0.479402,"marketCap":82106251},{"date":"2025-02-21","current":-0.355527,"twenty":-4.758834,"median":-2.764976,"eighty":-0.472606,"marketCap":80933305},{"date":"2025-02-28","current":-0.294727,"twenty":-4.758834,"median":-2.732828,"eighty":-0.45783,"marketCap":67092536},{"date":"2025-03-07","current":-0.242171,"twenty":-4.758834,"median":-2.711023,"eighty":-0.44909,"marketCap":55128483},{"date":"2025-03-14","current":-0.172611,"twenty":-4.758834,"median":-2.681951,"eighty":-0.441367,"marketCap":39293706},{"date":"2025-03-21","current":-0.186019,"twenty":-4.758834,"median":-2.616264,"eighty":-0.433644,"marketCap":42265764},{"date":"2025-03-28","current":-0.184905,"twenty":-4.758834,"median":-2.568557,"eighty":-0.424183,"marketCap":42012676},{"date":"2025-04-04","current":-0.178222,"twenty":-4.758834,"median":-2.531287,"eighty":-0.402997,"marketCap":40494145},{"date":"2025-04-11","current":-0.18045,"twenty":-4.758834,"median":-2.488661,"eighty":-0.391222,"marketCap":41000322},{"date":"2025-04-17","current":-0.183791,"twenty":-4.758834,"median":-2.484485,"eighty":-0.381387,"marketCap":41759587},{"date":"2025-04-25","current":-0.314116,"twenty":-4.758834,"median":-2.475296,"eighty":-0.371191,"marketCap":71370931},{"date":"2025-05-02","current":-0.318572,"twenty":-4.758834,"median":-2.439755,"eighty":-0.365832,"marketCap":72383285},{"date":"2025-05-09","current":-0.363545,"twenty":-4.758834,"median":-2.385601,"eighty":-0.36171,"marketCap":82601840},{"date":"2025-05-16","current":-0.486216,"twenty":-4.758834,"median":-2.379633,"eighty":-0.360886,"marketCap":92668953},{"date":"2025-05-23","current":-0.545195,"twenty":-4.758834,"median":-2.349838,"eighty":-0.360886,"marketCap":103909861},{"date":"2025-05-30","current":-0.460323,"twenty":-4.758834,"median":-2.31951,"eighty":-0.360886,"marketCap":87733920},{"date":"2025-06-06","current":-0.742271,"twenty":-4.758834,"median":-2.289397,"eighty":-0.360886,"marketCap":141470946},{"date":"2025-06-13","current":-0.693362,"twenty":-4.758834,"median":-2.263235,"eighty":-0.360886,"marketCap":132149217},{"date":"2025-06-20","current":-0.643014,"twenty":-4.758834,"median":-2.236155,"eighty":-0.36068,"marketCap":122553319},{"date":"2025-06-27","current":-0.706308,"twenty":-4.758834,"median":-2.20952,"eighty":-0.36068,"marketCap":134616733},{"date":"2025-07-03","current":-0.873176,"twenty":-4.758834,"median":-2.189024,"eighty":-0.36068,"marketCap":166420279},{"date":"2025-07-11","current":-0.851598,"twenty":-4.758834,"median":-2.160595,"eighty":-0.36068,"marketCap":162307752},{"date":"2025-07-18","current":-0.966679,"twenty":-4.758834,"median":-2.122302,"eighty":-0.36068,"marketCap":184241232},{"date":"2025-07-25","current":-0.86886,"twenty":-4.758834,"median":-2.107766,"eighty":-0.36068,"marketCap":165597774},{"date":"2025-08-01","current":-0.794058,"twenty":-4.758834,"median":-2.052632,"eighty":-0.36068,"marketCap":151341012},{"date":"2025-08-08","current":-0.684731,"twenty":-4.758834,"median":-2.01845,"eighty":-0.36068,"marketCap":130504206},{"date":"2025-08-15","current":-0.876202,"twenty":-4.758834,"median":-1.9793,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-08-22","current":-0.880054,"twenty":-4.758834,"median":-1.908081,"eighty":-0.36068,"marketCap":145618973},{"date":"2025-08-29","current":-0.818431,"twenty":-4.758834,"median":-1.85026,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-09-05","current":-0.826134,"twenty":-4.751199,"median":-1.806895,"eighty":-0.36068,"marketCap":136697023},{"date":"2025-09-12","current":-0.912791,"twenty":-4.720153,"median":-1.763529,"eighty":-0.36068,"marketCap":151035871},{"date":"2025-09-19","current":-0.876202,"twenty":-4.639607,"median":-1.590067,"eighty":-0.36068,"marketCap":144981691},{"date":"2025-09-26","current":-0.751031,"twenty":-4.603027,"median":-1.532247,"eighty":-0.36068,"marketCap":124270021},{"date":"2025-10-03","current":-0.758733,"twenty":-4.603027,"median":-1.488588,"eighty":-0.36068,"marketCap":125544585},{"date":"2025-10-10","current":-0.818431,"twenty":-4.584765,"median":-1.469289,"eighty":-0.36068,"marketCap":135422459},{"date":"2025-10-17","current":-0.768362,"twenty":-4.529097,"median":-1.4035,"eighty":-0.36068,"marketCap":127137790},{"date":"2025-10-24","current":-0.804951,"twenty":-4.504844,"median":-1.364904,"eighty":-0.36068,"marketCap":133191971},{"date":"2025-10-31","current":-0.733699,"twenty":-4.504844,"median":-1.327185,"eighty":-0.36068,"marketCap":121402251},{"date":"2025-11-07","current":-0.739476,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":122358174},{"date":"2025-11-14","current":-3.923437,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":137971587},{"date":"2025-11-21","current":-4.148775,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":145895817},{"date":"2025-11-28","current":-4.409887,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":155078071},{"date":"2025-12-05","current":-3.926346,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138073896},{"date":"2025-12-12","current":-3.945688,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":138754063},{"date":"2025-12-19","current":-3.394452,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":119369304},{"date":"2025-12-26","current":-3.239719,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":113927969},{"date":"2026-01-02","current":-3.036632,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":106786215},{"date":"2026-01-09","current":-3.626551,"twenty":-4.502695,"median":-1.274554,"eighty":-0.36068,"marketCap":127531308},{"date":"2026-01-16","current":-3.558856,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":125150724},{"date":"2026-01-23","current":-3.268732,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":114948219},{"date":"2026-01-30","current":-2.89157,"twenty":-4.504844,"median":-1.274554,"eighty":-0.36068,"marketCap":101684963},{"date":"2026-02-06","current":-2.678813,"twenty":-4.430404,"median":-1.274554,"eighty":-0.36068,"marketCap":94203126},{"date":"2026-02-13","current":-2.756179,"twenty":-4.343462,"median":-1.274554,"eighty":-0.36068,"marketCap":96923794},{"date":"2026-02-20","current":-3.104328,"twenty":-4.263259,"median":-1.274554,"eighty":-0.36068,"marketCap":109166800},{"date":"2026-02-27","current":-3.24939,"twenty":-4.192205,"median":-1.274554,"eighty":-0.36068,"marketCap":114268052},{"date":"2026-03-06","current":-2.823875,"twenty":-4.177787,"median":-1.274554,"eighty":-0.36068,"marketCap":99304379},{"date":"2026-03-13","current":-2.8819,"twenty":-4.177787,"median":-1.274554,"eighty":-0.36068,"marketCap":101344880},{"date":"2026-03-20","current":1272.154157,"twenty":-4.177787,"median":-1.228688,"eighty":-0.36068,"marketCap":146297728},{"date":"2026-03-27","current":1148.611626,"twenty":-4.177787,"median":-1.174531,"eighty":-0.355527,"marketCap":132090337},{"date":"2026-04-02","current":1135.255678,"twenty":-4.177787,"median":-1.156906,"eighty":-0.352436,"marketCap":130554403},{"date":"2026-04-10","current":1485.849348,"twenty":-4.177787,"median":-1.142806,"eighty":-0.347999,"marketCap":170872675},{"date":"2026-04-17","current":1549.290104,"twenty":-4.177787,"median":-1.132758,"eighty":-0.342131,"marketCap":178168362},{"date":"2026-04-24","current":1255.459226,"twenty":-4.177787,"median":-1.116527,"eighty":-0.332856,"marketCap":144377811},{"date":"2026-05-01","current":1305.544035,"twenty":-4.177787,"median":-1.097827,"eighty":-0.324612,"marketCap":150137564},{"date":"2026-05-08","current":1252.120235,"twenty":-4.177787,"median":-1.083327,"eighty":-0.321005,"marketCap":143993827},{"date":"2026-05-15","current":2.301732,"twenty":-4.177787,"median":-1.071742,"eighty":-0.317458,"marketCap":148708023},{"date":"2026-05-22","current":2.031697,"twenty":-4.148775,"median":-1.054822,"eighty":-0.304517,"marketCap":131261830},{"date":"2026-05-29","current":2.186003,"twenty":-4.07903,"median":-1.045617,"eighty":-0.294521,"marketCap":141231083},{"date":"2026-06-05","current":2.182788,"twenty":-4.02764,"median":-1.033247,"eighty":-0.285452,"marketCap":141023390},{"date":"2026-06-12","current":2.185024,"twenty":-3.964831,"median":-1.007446,"eighty":-0.282361,"marketCap":141167841},{"date":"2026-06-18","current":1.907867,"twenty":-3.93641,"median":-1.003075,"eighty":-0.275147,"marketCap":123261595},{"date":"2026-06-26","current":1.856304,"twenty":-3.909198,"median":-0.992923,"eighty":-0.255517,"marketCap":119930201},{"date":"2026-07-02","current":2.197915,"twenty":-3.836934,"median":-0.988811,"eighty":-0.229663,"marketCap":142000689},{"date":"2026-07-10","current":2.088341,"twenty":-3.802203,"median":-0.984745,"eighty":-0.197158,"marketCap":134921476},{"date":"2026-07-17","current":3.222749,"twenty":-3.751668,"median":-0.975654,"eighty":-0.191213,"marketCap":208212155},{"date":"2026-07-24","current":4.287719,"twenty":-3.686298,"median":-0.972781,"eighty":-0.186019,"marketCap":277016662},{"date":"2026-07-31","current":5.479137,"twenty":-3.637981,"median":-0.966679,"eighty":-0.182232,"marketCap":353990598},{"date":"2026-08-07","current":5.188209,"twenty":-3.623771,"median":-0.958801,"eighty":-0.178222,"marketCap":335194637},{"date":"2026-08-14","current":3.425019,"twenty":-3.571435,"median":-0.94843,"eighty":1.866617,"marketCap":315142849},{"date":"2026-08-21","current":3.66477,"twenty":-3.493031,"median":-0.938591,"eighty":1.955564,"marketCap":337202848},{"date":"2026-08-28","current":3.821343,"twenty":-3.467451,"median":-0.926271,"eighty":1.991835,"marketCap":351609378},{"date":"2026-09-04","current":4.031737,"twenty":-3.410608,"median":-0.914892,"eighty":2.030878,"marketCap":370968153},{"date":"2026-09-11","current":3.371197,"twenty":-3.387092,"median":-0.9036,"eighty":2.081358,"marketCap":310190604},{"date":"2026-09-17","current":3.52777,"twenty":-3.338362,"median":-0.895633,"eighty":2.130035,"marketCap":324597134}],"updateTime":1789770193462},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGEN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2645832857","title":"Agenus shareholders approve 5 million-share increase to 2019 equity plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2645832857","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645832857?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:14","pubTimestamp":1782224093,"startTime":"0","endTime":"0","summary":"Agenus held its annual shareholder meeting on June 16, 2026.Shareholders backed amendments to the 2019 Employee Stock Purchase Plan, lifting the share pool to 200,000 from 150,000.An amendment to the Amended and Restated 2019 Equity Incentive Plan was adopted, increasing the shares available for issuance by 5 million.A one-time stock option exchange program was authorized under the 2019 EIP, the Amended and Restated 2009 plan, and the 2015 inducement plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solel","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL2KXhNH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235179","title":"Agenus Nears Key Readout as Botensilimab Pancreatic Cancer Trial Reaches Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235179","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235179?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:30","pubTimestamp":1781195441,"startTime":"0","endTime":"0","summary":"Agenus Inc. ($AGEN) announced an update on their ongoing clinical study. The Phase II study “A Randomized, Open-Label, Phase II Trial of Nab-paclit...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agenus-nears-key-readout-as-botensilimab-pancreatic-cancer-trial-reaches-completion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agenus-nears-key-readout-as-botensilimab-pancreatic-cancer-trial-reaches-completion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925164","title":"Agenus announces virtual annual shareholders meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925164","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925164?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:31","pubTimestamp":1780432311,"startTime":"0","endTime":"0","summary":"Agenus will hold its 2026 annual shareholders meeting in a virtual-only format on June 16, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLbbqGlS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673219","title":"Backlash over Trump's $1.776 billion fund tests Blanche's bid for US attorney general","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673219","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639673219?lang=en_us&edition=fundamental","pubTime":"2026-05-29 22:25","pubTimestamp":1780064714,"startTime":"0","endTime":"0","summary":"UPDATE 1-Backlash over Trump's $1.776 billion fund tests Blanche's bid for US attorney generalBlanche draws Republican ire over planned fund for 'weaponization' victimsActing attorney general has pursued causes close to TrumpCourts, Congress voice growing skepticism over DOJ's directionUpdates headline, adds court ruling in paragraph 4By Andrew Goudsward. Lawmakers, including many in Trump's Republican Party, have voiced deep skepticism over the proposal and a federal judge on Friday. the Trump administration from creating or operating it at least through mid-June. The ruling was made in one of three lawsuits seeking to scuttle the fund.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL6N4260TK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637435277","title":"Agenus reports Phase 2 BOT+BAL melanoma trial shows 22% response rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2637435277","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637435277?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:01","pubTimestamp":1779397279,"startTime":"0","endTime":"0","summary":"Agenus disclosed first Phase 2 results from its C-800-23 study of botensilimab with balstilimab in advanced cutaneous melanoma that had progressed on prior checkpoint therapy; the full dataset is scheduled for presentation on May 31, 2026 at the ASCO annual meeting.The readout showed durable tumor responses in a heavily pretreated, checkpoint-refractory population, with survival results that compared favorably with published benchmarks in patients previously exposed to both PD-1 and CTLA-4 therapy.Safety was in line with established CTLA-4 and PD-1 inhibitor profiles, with no new safety signals or treatment-related deaths reported.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6VbGP6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352711","title":"Agenus says AI model predicts BOT+BAL response, survival in MSS metastatic colorectal cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352711","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352711?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397234,"startTime":"0","endTime":"0","summary":"Agenus flagged new retrospective data that uses Noetik’s AI model to predict which patients may benefit from its investigational botensilimab and balstilimab immunotherapy combination.Results will be presented May 30, 2026 at the ASCO annual meeting, based on pretreatment routine tumor pathology images from 113 efficacy-evaluable patients in the C-800-01 Phase 1b trial.In microsatellite-stable metastatic colorectal cancer patients without active liver metastases, the model showed predictive value for both treatment response and survival, with supportive signals in ovarian cancer and sarcomas.The work targets a key commercial issue for the regimen, which has not been closely linked to standard biomarkers, by proposing an image-based approach that could support future patient selection if confirmed prospectively.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-g","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL6yT2YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635030081","title":"Agenus Announces Resignation of Principal Accounting Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2635030081","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635030081?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:32","pubTimestamp":1778877153,"startTime":"0","endTime":"0","summary":"Agenus ( ($AGEN) ) has shared an update. On May 12, 2026, Agenus Inc. disclosed that its Senior Director of Financial Reporting and Compliance and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/agenus-announces-resignation-of-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/agenus-announces-resignation-of-principal-accounting-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1989772923.USD","PFG","BK4139","BK4534","BK4162","BK4566","LU1989772840.SGD","AGEN","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635300830","title":"Agenus announces publication of Phase 1b BOT+BAL data","url":"https://stock-news.laohu8.com/highlight/detail?id=2635300830","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635300830?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:23","pubTimestamp":1778876606,"startTime":"0","endTime":"0","summary":"Agenus (AGEN) announced the publication of Phase 1b data evaluating botensilimab, an Fc-enhanced anti-CTLA-4 antibody, in combination with balstili...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-announces-publication-of-phase-1b-botbal-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-announces-publication-of-phase-1b-botbal-data-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BAL","BOT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635703779","title":"Agenus principal accounting officer Charette resigns effective May 29","url":"https://stock-news.laohu8.com/highlight/detail?id=2635703779","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635703779?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:16","pubTimestamp":1778876163,"startTime":"0","endTime":"0","summary":"Agenus disclosed resignation of Austin Charette, senior director of financial reporting and compliance, from role as principal accounting officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL6hGKVy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635037431","title":"Agenus reports Phase 1b BOT+BAL trial shows 17% response in post-immunotherapy HCC","url":"https://stock-news.laohu8.com/highlight/detail?id=2635037431","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635037431?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:11","pubTimestamp":1778875889,"startTime":"0","endTime":"0","summary":"Agenus reported Phase 1b results already published in Liver Cancer on botensilimab with balstilimab in advanced hepatocellular carcinoma patients whose disease progressed following prior immunotherapy.Study showed signs of tumor shrinkage in some patients, with durable disease control in others, supporting potential activity in a setting with limited post-immunotherapy options.Safety profile was described as manageable and consistent with earlier experience, with no treatment-related deaths or new safety signals.Findings support continued clinical development of botensilimab-based combinations in post-immunotherapy liver cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Agenus Inc. published the original content used to generate t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1vCY1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089955","title":"MiNK Therapeutics Q1 FY26 net loss narrows to $2.74 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089955?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:31","pubTimestamp":1778844688,"startTime":"0","endTime":"0","summary":"Mink Therapeutics posted a first-quarter net loss of USD 2.74 million, narrowing from USD 2.77 million a year earlier, while loss per share improved to USD 0.57 from USD 0.70.Cash and cash equivalents fell to USD 9.53 million at March 31, 2026 from USD 13.36 million at end-2025, while cash used in operations rose to USD 1.73 million from USD 1.34 million a year earlier.During the quarter, it repaid about USD 5.2 million tied to the Agenus convertible note and raised about USD 3 million via its at-the-market sales agreement.MiNK initiated a randomized Phase 2 trial of agenT-797 in severe acute lung injury and critical illness, with preliminary data expected in the second half of 2026.CEO Jennifer Buell said the off-the-shelf iNKT therapy is designed for use without lymphodepletion or HLA matching in settings where speed and tolerability matter, including severe acute lung injury and critical illness.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL1fLrLj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","SG9999014021.USD","INKT","IE00B64PRP62.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4585","BK4139","BK4588","NDAQ","IE00BN0W2V16.EUR","AGEN","LU2210149790.SGD","SG9999014039.USD","LU2210150020.SGD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634129778","title":"Agenus Buy Rating Reaffirmed as Late-Stage Strategy Advances; $23 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2634129778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634129778?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:16","pubTimestamp":1778580987,"startTime":"0","endTime":"0","summary":"Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Agenus. The associated price target remains the same with $23.00. Emily...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/agenus-buy-rating-reaffirmed-as-late-stage-strategy-advances-23-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/agenus-buy-rating-reaffirmed-as-late-stage-strategy-advances-23-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634256625","title":"Agenus Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634256625","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634256625?lang=en_us&edition=fundamental","pubTime":"2026-05-12 07:04","pubTimestamp":1778540698,"startTime":"0","endTime":"0","summary":"Agenus Inc reports results for the quarter ended March 31 - Earnings SummaryAgenus Inc AGEN.OQ reported quarterly breakeven results per share for the quarter ended March 31, higher than the same quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2TX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634723898","title":"Agenus reports Q1 revenue $33.7M vs. $24.1M last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2634723898","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634723898?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:42","pubTimestamp":1778510535,"startTime":"0","endTime":"0","summary":"“First quarter 2026 was a defining quarter for Agenus (AGEN) and for BOT and BAL,” said Garo H. Armen, Ph.D., Chairman and Chief Executive Officer ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-reports-q1-revenue-33-7m-vs-24-1m-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-reports-q1-revenue-33-7m-vs-24-1m-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634715280","title":"Agenus provides 2026 strategic priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2634715280","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634715280?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:38","pubTimestamp":1778510314,"startTime":"0","endTime":"0","summary":"The company said, “2026 Strategic Priorities: Support responsible authorized access through France’s AAC framework and paid named-patient programs ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-provides-2026-strategic-priorities-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-provides-2026-strategic-priorities-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634280760","title":"Agenus announces conclusion of SEC investigation with no enforcement action","url":"https://stock-news.laohu8.com/highlight/detail?id=2634280760","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634280760?lang=en_us&edition=fundamental","pubTime":"2026-05-11 22:36","pubTimestamp":1778510163,"startTime":"0","endTime":"0","summary":"The company said, “On May 4, 2026, the U.S. Securities and Exchange Commission informed Agenus (AGEN) that it has concluded its investigation as to...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agenus-announces-conclusion-of-sec-investigation-with-no-enforcement-action-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agenus-announces-conclusion-of-sec-investigation-with-no-enforcement-action-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634728121","title":"Agenus Q1 Sales $33.700M May Not Be Comparable To $129.500M Estimate, Net Income Of $39.2M Vs. Loss of $26.4M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2634728121","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634728121?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:54","pubTimestamp":1778504050,"startTime":"0","endTime":"0","summary":"Agenus Q1 Sales $33.700M May Not Be Comparable To $129.500M Estimate, Net Income Of $39.2M Vs. Loss of $26.4M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/AGEN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634259281","title":"Immuno-oncology developer Agenus' Q1 revenue rises, posts profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2634259281","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634259281?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:53","pubTimestamp":1778504036,"startTime":"0","endTime":"0","summary":"Immuno-oncology developer Agenus' Q1 revenue rises, posts profitOverviewUS immuno-oncology developer's Q1 revenue grew yr/yr, driven by BOT+BAL programCompany reported positive net income for Q1, comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL1N41O0GI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGEN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281944","title":"Press Release: Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281944","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281944?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:46","pubTimestamp":1778503560,"startTime":"0","endTime":"0","summary":"--  Authorized access interest continues to expand across regions. --  Phase 3 BATTMAN trial commenced patient enrollment in April 2026,--  Zydus collaboration closed in January, delivering strategic capital,strengthening Agenus' balance sheet and securing dedicated U.S. biologics. --  Agenus continues to align operating priorities around BOT+BAL,recommended; Related putative securities class action dismissed in its. entirety by the U.S. District Court for the District of Massachusetts in. \"First quarter 2026 was a defining quarter for Agenus and for BOT and BAL,\" said Garo H. Armen, Ph.D., Chairman and Chief Executive Officer of Agenus. \"We saw continued physician requests and engagement treating patients with BOT and BAL through regulatory-authorized access pathways. Additionally, we advanced the program into Phase 3 enrollment and closed a transformative collaboration with Zydus that secured both capital and U.S. manufacturing capacity. BOT+BAL's maturing data, particularly the dura","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BAL","AGEN","BOT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634281992","title":"Agenus Q1 FY26 net income swings to $39.2 million; revenue rises to $33.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634281992","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634281992?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:45","pubTimestamp":1778503535,"startTime":"0","endTime":"0","summary":"Agenus posted Q1 2026 revenue of USD 33.7 million, including USD 4.6 million in pre-commercial product revenue, while operating income swung to USD 15.1 million.Net income swung to USD 39.2 million, while cash and cash equivalents rose to USD 35 million.Paid named-patient activity broadened to additional countries in South and Central America and Europe; in April, BAP Pharma was named global partner for BOT+BAL access programs.Phase 3 BATTMAN trial began patient enrollment in April, evaluating botensilimab plus balstilimab versus best supportive care in refractory MSS/pMMR metastatic colorectal cancer.CEO Garo H. Armen said maturing BOT+BAL data, including durability of survival outcomes in refractory MSS colorectal cancer, underpins planned regulatory submissions in the US and Europe.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLHPw4Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGEN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":101,"code":"91000000","status":"200"}]}}